In summary, our pan-cancer analysis of YKT6 revealed statistical association of YKT6 level with survival prognosis, genetic alteration, DNA methylation and immune infiltration across most tumors, which can contribute to understanding the role of YKT6 in tumoeigenesis from perspective of clinical tumor samples. The gene discussed is YKT6; the disease is cancer.